LH

LH

USD

Labcorp Holdings Inc. Common Stock

$252.720+5.880 (2.382%)

실시간 가격

Healthcare
Diagnostics & Research
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$246.840

고가

$252.760

저가

$244.520

거래량

0.69M

기업 기본 정보

시가총액

21.0B

산업

Diagnostics & Research

국가

United States

거래 통계

평균 거래량

0.62M

거래소

NYQ

통화

USD

52주 범위

저가 $209.38현재가 $252.720고가 $293.72

관련 뉴스

Analyst Upgrades

UBS Maintains Buy on Labcorp Hldgs, Lowers Price Target to $320

UBS analyst Kevin Caliendo maintains Labcorp Hldgs with a Buy and lowers the price target from $325 to $320.

더 보기
UBS Maintains Buy on Labcorp Hldgs, Lowers Price Target to $320
Reuters

Labcorp cuts growth outlook for research unit as biotech funding crunch persists

Labcorp forecast lower annual revenue growth for its contract research unit on Tuesday, as a prolonged funding crunch continues to weigh on its early-stage drug development clients.

더 보기
Labcorp cuts growth outlook for research unit as biotech funding crunch persists
Analyst Upgrades

Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support

Labcorp posts Q3 EPS of $4.18 and sales of $3.56 billion, exceeding estimates, while revising 2025 guidance amid strong diagnostics and lab growth.

더 보기
Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support
PR Newswire

Labcorp Announces 2025 Third Quarter Results

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the third quarter ended...

더 보기
Labcorp Announces 2025 Third Quarter Results
PR Newswire

Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the...

더 보기
Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings